Tribunal classifies viral preparation and diluent as vaccines under heading 30.02, granting duty exemption

The Tribunal classified the viral preparation and diluent as vaccines under heading 30.02, rejecting the department's argument for classification under heading 3823.00. The Tribunal found that both components are essential for the vaccine and cleared together, meeting the requirements of Note 2 to Section VI. The extended period for demanding duty was challenged by the appellant, asserting the product was exempt from duty, which the Tribunal upheld due to the classification as a vaccine at nil duty rate. The appeal was allowed, the impugned order set aside, and consequential relief granted.

---

---

Issues:
Classification of viral preparation and diluent as vaccines under heading 30.02 vs. heading 3823.00; Invocation of extended period for demanding duty; Applicability of Note 2 to Section VI of the tariff.

Classification Issue:
The appellant, a vaccine manufacturer, claimed that the viral preparation and diluent should be classified together as vaccines under heading 30.02 of the tariff, while the department argued for classification under heading 3823.00 due to non-intimation regarding diluents. The Commissioner upheld the classification under heading 38.23, invoking the extended period for duty demand and penalty. The appellant contended that both components are essential for the vaccine, and the diluent is solely for reconstitution. The Departmental Representative argued that diluent usage does not make it part of the vaccine, citing a Supreme Court judgment. The Tribunal analyzed the applicability of Note 2 to Section VI, which requires identifiable constituents intended for combined use without repacking. The Tribunal found that the viral preparation and diluent are cleared together, satisfying the note's requirements, leading to classification as vaccines under heading 30.02.

Extended Period Issue:
The appellant challenged the invocation of the extended period under Section 11A, asserting that they believed the entire product was a vaccine, exempt from duty, hence no declaration was filed. The Departmental Representative supported the extended period application, emphasizing the Commissioner's findings. The Tribunal considered the appellant's belief and concluded that since the product was classified as a vaccine at nil duty rate, the demand for duty could not be sustained, rendering the extended period issue moot.

Applicability of Note 2 to Section VI Issue:
The Tribunal examined the applicability of Note 2 to Section VI, focusing on the identifiable constituents intended for combined use without repacking. It was established that the viral preparation and diluent are complementary, with the diluent necessary for reconstitution. The leaflet and labels indicated the necessity of using both components together, satisfying the note's requirements. Consequently, the product was classified as a vaccine under heading 30.02, leading to the appeal being allowed, impugned order set aside, and granting consequential relief.

---